News
Anne Wojcicki to buy back 23andMe and its data
Digest more
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results